Document Classification

Section Type: RESULTS

Text: Overall survival was 27. 2 % (95 % CI 22. 2-32. 5) at 2 years, 16. 0 % (12. 0-20. 6) at 3 years, 12. 1 % (8. 5-16. 4) at 4 years, and 9. 8 % (6. 4-14. 0) at 5 years with temozolomide, versus 10. 9 % (7. 6-14. 8), 4. 4 % (2. 4-7. 2), 3. 0 % (1. 4-5. 7), and 1. 9 % (0. 6-4. 4) with radiotherapy alone (hazard ratio 0. 6, 95 % CI 0. 5-0. 7 ; p < 0. 0001).